(Corrects third paragraph to " ... outside the United States" from " ... in the United States")
July 30 Pfizer Inc agreed to buy two of Baxter International Inc's vaccines and a part of a facility involved in their production for $635 million.
The deal will give Pfizer access to Baxter's NeisVac-C, a meningitis vaccine, and FSME-IMMUN, an encephalitis vaccine.
Both vaccines are already being sold outside the United States. (Reporting by Anand Basu; Editing by Simon Jennings)